Search Browse Earnings

PROTHENA CORP PUBLIC LTD CO — SlamSEC

PROTHENA CORP PUBLIC LTD CO

Nasdaq:PRTA

Pharmaceutical Preparations·DUBLIN 2, L2

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$91.4M

+69.5% YoY

FY 2025

Adj. EBITDA

-$190.1M

-208.1% margin

FY 2025

Net Income

-$147.0M

-160.9% margin

FY 2025

EPS (Diluted)

-$2.76

FY 2025

Stock Price

$9.21

-1.1%

2026-03-13

52W Range

$4.32 – $13.95

P/E Ratio

-3.3x

Market Cap

$495.8M

Cash

$618.8M

FY 2025

Total Debt

—

Net Cash

$618.8M

FY 2025

Enterprise Value

-$123.0M

Debt / EBITDA

3.3x

FY 2025

EV / EBITDA

0.6x

Employees

—